ArmaGen Technologies is a startup based in the United States, 2 tracked investors.
ArmaGen Technologies is a company headquartered in the United States. Brouky records 2 investors associated with the company.
ArmaGen Technologies develops biologic medicines that use novel antibody engineering and drug delivery technologies to extend the half-life and improve tissue targeting of therapeutics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.